Purchase Order 75N95022P00396
- Not listed
- This purchase order contract valued at $568,500 was awarded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to Dr. Gian Luca Araldi as the prime contractor. The contract is for process chemistry consulting services to support the NIH Blueprint Neurotherapeutics Network and NIH Helping to End Addiction Long-term Initiative programs. Dr. Araldi will provide technical guidance and support as the key personnel consultant over a three-year period...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $568,500.00 purchase order contract to Araldi Gian Luca, a sole proprietorship providing scientific research and development services. This contract is for pharmaceutics formulation/chemistry manufacturing and control consulting services for small molecules and/or biologics in support of the NINDS's neuroscience drug discovery and development programs, including the National Institutes of Health's (NIH) Blueprint...
- The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $479.6K purchase order contract to Araldi Gian Luca, a sole proprietorship specializing in scientific consulting services, to provide process chemistry consultant support services for the NINDS Blueprint Neurotherapeutics Network (BPN). The contract, issued on September 12, 2019, with an ultimate completion date of September 19, 2022, was designated as a total small business set-aside under solicitation...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to the sole proprietorship Araldi Gian Luca for $130,000.00. The contract has a period of performance from August 1, 2019 to August 4, 2024 and is not set aside. Araldi Gian Luca, a total small business, will provide scientific research and development services to support neuroscience drug discovery and development programs...
- This federal contract award is for pharmaceutical formulation, chemistry manufacturing, and controls (CMC) consulting services for small molecules and/or biologics, provided by a sole proprietor, Araldi Gian Luca, to the National Institute on Drug Abuse (NIDA), which is part of the U.S. Department of Health and Human Services. The contract is a labor-hour purchase order with a ceiling value of $8,460 and a total small business set-aside. It has a base period from September 20, 2025, through...
- The National Institute of Neurological Disorders and Stroke (NINDS) has awarded a $12,000 purchase order to NDC Medchem Consulting LLC, a small business entity located in Poway, California, for medicinal chemistry and bioactivity assay development consulting services. The contract was awarded on September 29, 2025, with an ultimate completion date of September 28, 2026. This award is designated as a Total Small Business set-aside, limiting competition to qualified small business concerns. The...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services, awarded a $9,000.00 Purchase Order contract for Medicinal Chemistry Consulting Services to Nigel J Liverton, a small business located in San Antonio, Texas. The contract, which runs through September 28, 2026, is to provide technical guidance and recommendations to support the NIH Blueprint Neurotherapeutics Network drug discovery and development programs, as well as other NIH...
- This purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke is for Medicinal Chemistry Consulting Services for NINDS' HEAL Program. The $483,600 contract was awarded to Graham Johnson as a total small business set-aside. Key personnel under the contract must have a minimum of 15 years of experience in medicinal chemistry, including managing drug discovery projects. The contractor will...
- <p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>
- This is a $547,312.50 labor-hour purchase order awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Romero Donna L, a woman-owned small business. The contract provides Medicinal Chemistry Consultant Support Services to NINDS for its Blueprint Neurotherapeutics Network drug discovery and development programs. The requirement was set aside for total small business participation. The base period of performance is...
This is a $532,500.00 purchase order contract for medicinal chemistry consulting services awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency under the National Institutes of Health (NIH), to a small business vendor named Araldi Gian Luca. The contract was set aside for total small businesses and has a period of performance through July 26, 2025. Araldi Gian Luca will provide technical guidance, collaboration, and management oversight on multi-disciplinary teams supporting neuroscience drug discovery and development programs under the NIH Blueprint Neurotherapeutics Network, NIH Helping to End Addiction Long-termSM Initiative, and other NIH neuroscience efforts. This award was issued under a competitive solicitation seeking executive-level, industry-experienced consultants with expertise in small molecule medicinal chemistry.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Medicinal Chemistry Consulting Services | 75N95022P00397 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 2/4 | 7/28/22, 11:40 AM | |
Medicinal Chemistry Consulting Services | 75N95022R00048 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/4 | 5/26/22, 6:39 PM | |
Medicinal Chemistry Consulting Services | 75N95022P00396 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 3/4 | 7/28/22, 11:44 AM | |
Medicinal Chemistry Consulting Services | 75N950RRP00383 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 4/4 | 7/28/22, 11:51 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Exercise an Option | $13.2k | 12/2/24 | |
| P00005 | Exercise an Option | $11.0k | 4/22/24 | |
| P00004 | Exercise an Option | $13.2k | 11/20/23 | |
| P00003 | Exercise an Option | $22.0k | 7/25/23 | |
| P00002 | Exercise an Option | $17.6k | 3/20/23 |